Rheumatology

Power Doppler ultrasound may provide important signals in predicting treatment response for patients with rheumatoid arthritis (RA), though its ability to forecast remission remains uncertain, according to a new systematic review.

IL-1 pathway inhibition is increasingly replacing corticosteroids as the preferred second-line treatment for recurrent pericarditis, according to real-world registry data from the RESONANCE study.

Ultrasound imaging may offer a more precise way to distinguish between inflammatory and non-inflammatory phenotypes in patients with difficult-to-treat psoriatic arthritis (D2T-PsA), according to new multicentre cross-sectional study findings.

Recent advancements in machine learning (ML) are offering new opportunities to predict the onset and progression of knee osteoarthritis with greater accuracy, supporting earlier intervention and more personalized care.

New research has identified clinical features that may predict resistance to colchicine in patients with the syndrome of undifferentiated recurrent fever (SURF), offering potential guidance for more targeted treatment approaches.

A new bibliometric study highlights the rapid rise in artificial intelligence (AI) research within rheumatology, revealing both the field’s growing significance and the limited group of authors driving this trend.

A new interdisciplinary cardio-rheumatology model is paving the way for earlier detection and personalized treatment of cardiac complications in patients with systemic sclerosis, according to a recent review.

Retroperitoneal fibrosis (RPF) complicated by fibrosing mediastinitis (FM) is an uncommon but life-threatening condition that warrants early detection and intervention.